drugset / Trial / NCT02455869

Comparison of Alendronate With Atorvastatin in Chronic Periodontitis

NCT02455869

RandomizedParallel-groupDouble-blindTreatment

Summary

The present study is designed as a single-centre, randomized, controlled clinical trial to evaluate and compare the clinical efficacy of two local drug delivery systems containing 1% ALN gel and 1.2% ATV gel in treatment of intrabony defects in patients with chronic periodontitis as an adjunct to SRP.

Timeline

Start
2014-07
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alendronic Acid Small molecule 1 % Other
Comparator Atorvastatin Small molecule 1.2 %

Indications